SUMMARY
The research of M. Yasir Qureshi, M.B.B.S., pertains to pediatric cardiology. Dr. Qureshi, a physician and scientist, specializes in diagnosing congenital heart conditions from fetal stages through adulthood. His research centers on using cutting-edge imaging techniques.
Dr. Qureshi focuses on advanced fetal and transthoracic echocardiography, magnetic resonance imaging, and computerized tomography. Dr. Qureshi uses these tests to thoroughly study various heart conditions.
Dr. Qureshi's research includes creating standardized protocols for ventricular function assessment and leading clinical trials on stem cell-based therapy for congenital heart disease. He started an imaging core lab for complex heart conditions such as hypoplastic left heart syndrome and Ebstein anomaly. With a robust background in advanced imaging, Dr. Qureshi encourages collaboration among researchers, cardiologists, obstetricians and radiologists. This teamwork advances care for complex heart conditions, even before birth.
Focus areas
- Fetal cardiac imaging. Dr. Qureshi studies fetal cardiac imaging to provide fetal and maternal care and aid fetal surgery.
- Advanced cardiac imaging with magnetic resonance imaging and computerized tomography. Dr. Qureshi explores these modalities in pediatric cardiology.
- Stem cell-based therapy for congenital heart disease. Dr. Qureshi researches stem cell therapy for congenital heart disease and contributes to clinical trials involving these therapies.
- Hypoplastic left heart syndrome. Dr. Qureshi explores the causes and symptoms of hypoplastic left heart syndrome.
- Ebstein anomaly. Dr. Qureshi focuses on what causes Ebstein anomaly and how it presents.
Significance to patient care
Developing novel heart imaging protocols and stem cell therapy for congenital heart disease improves patient care. Dr. Qureshi's research improves the accuracy and detailed information about the heart's condition.
These protocols help healthcare teams see how the heart is working and identify problems more accurately. Stem cell therapy offers a potential method to repair damaged heart tissue and improve heart function in babies born with congenital heart defects. Thus, healthcare teams can make better decisions about treatment, leading to earlier interventions and better outcomes for children with congenital heart defects.
Professional highlights
- Teacher of the Year Award in Pediatrics and Subspecialties, Mayo Fellows Association, Mayo School of Graduate Medical Education, Mayo Clinic, 2021.
- Favorite Faculty Award, Mayo Clinic Department of Pediatric and Adolescent Medicine Residency Program, Mayo Clinic, 2018-2019.